Tshabalala Wanda S, Pillay Somasundram, Wilson Douglas P K
Department of Internal Medicine, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Department of Internal Medicine, Edendale Hospital, Pietermaritzburg complex, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Afr J Lab Med. 2020 Feb 25;9(1):1028. doi: 10.4102/ajlm.v9i1.1028. eCollection 2020.
Bone marrow aspiration and trephine biopsy (BMAT) are widely performed in adults to evaluate haematological and malignant conditions. However, the diagnostic yield from the procedure in unselected patients in the South African public sector has not previously been described.
We identified the main indications and most common diagnoses encountered for BMAT and described the demographic and blood profiles of patients, including HIV-positive patients, who had undergone the procedure at a tertiary hospital in KwaZulu-Natal.
We retrospectively reviewed laboratory data from January 2016 to December 2016 for all patients aged ≥ 13 years who underwent the procedure and stratified findings by demographic data.
Among 120 BMAT biopsies studied, 80 (67%) cases were performed to evaluate suspected malignancy and a further 40 (33%) cases for non-malignant indications. The main indications for bone marrow examination were: cytopenias 38 (32%), lymphoma 35 (29%), leukaemia 21 (18%), and multiple myeloma 17 (14%). BMAT results revealed that 60 cases (50%) were malignant in origin, 30 cases (25%) were non-malignant and 30 cases (25%) were classified as normal. The common diagnoses were: leukaemia, 24 (20%); multiple myeloma, 16 (13%) and lymphoma, 13 (11%). Cases aged ≥ 50 years were more likely to have a malignant diagnosis (odds ratio: 5.8 (95% confidence interval: 2.2-17.1) p-value < 0.001).
The diagnostic yield of BMAT was high, with significant abnormalities detected in three quarters of cases. Haematological malignancy was the more common diagnosis. Increasing age was associated with an increase in reporting of haematology malignancy.
骨髓穿刺和活检(BMAT)在成人中广泛用于评估血液系统疾病和恶性疾病。然而,此前尚未描述南非公共部门未选患者进行该检查的诊断率。
我们确定了BMAT的主要适应证和最常见诊断,并描述了在夸祖鲁 - 纳塔尔省一家三级医院接受该检查的患者(包括HIV阳性患者)的人口统计学和血液学特征。
我们回顾性分析了2016年1月至2016年12月期间所有年龄≥13岁接受该检查患者的实验室数据,并根据人口统计学数据对结果进行分层。
在研究的120例BMAT活检中,80例(67%)用于评估疑似恶性肿瘤,另外40例(33%)用于非恶性适应证。骨髓检查的主要适应证为:血细胞减少38例(32%)、淋巴瘤35例(29%)、白血病21例(18%)和多发性骨髓瘤17例(14%)。BMAT结果显示,60例(50%)起源于恶性肿瘤,30例(25%)为非恶性,30例(25%)分类为正常。常见诊断为:白血病24例(20%)、多发性骨髓瘤16例(13%)和淋巴瘤13例(11%)。年龄≥50岁的患者更有可能被诊断为恶性肿瘤(优势比:5.8(95%置信区间:2.2 - 17.1),p值<0.001)。
BMAT的诊断率较高,四分之三的病例检测到明显异常。血液系统恶性肿瘤是更常见的诊断。年龄增加与血液系统恶性肿瘤报告增加相关。